Cite
, Hage CA, Klesney-Tait J, et al. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction. Transfus Med. 2021;31(4):292-302doi: 10.1111/tme.12779.
, Hage, C. A., Klesney-Tait, J., Wille, K., Arcasoy, S., Yung, G., Hertz, M., Chan, K. M., Morrell, M., Goldberg, H., Vedantham, S., Derfler, M. C., Commean, P., Berman, K., Spitznagel, E., Atkinson, J., & Despotis, G. (2021). Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction. Transfusion medicine (Oxford, England), 31(4), 292-302. https://doi.org/10.1111/tme.12779
, et al. "Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction." Transfusion medicine (Oxford, England) vol. 31,4 (2021): 292-302. doi: https://doi.org/10.1111/tme.12779
, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction. Transfus Med. 2021 Aug;31(4):292-302. doi: 10.1111/tme.12779. Epub 2021 May 05. PMID: 33955079; PMCID: PMC8453798.
Copy
Download .nbib